ABL Bio Inc (298380) — Capital Reinvestment Ratio
ABL Bio Inc (298380) has a Capital Reinvestment Ratio of 0.01x as of March 2026, meaning it reinvests 0% of its operating cash flow (₩32.84 Billion) in capital expenditures (₩243.74 Million). Check ABL Bio Inc tangible book value ratio to evaluate the tangible quality of the company's equity base.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
ABL Bio Inc Capital Reinvestment Ratio (2022–2022)
This chart tracks ABL Bio Inc's Capital Reinvestment Ratio across 1 annual periods. For the full cash flow conversion analysis, see ABL Bio Inc cash flow conversion.
Annual Capital Reinvestment Ratio for ABL Bio Inc (2022–2022)
Year-by-year Capital Reinvestment Ratio for ABL Bio Inc from 2022 to 2022. See ABL Bio Inc free cash flow ratio to measure how efficiently the company converts operating cash flow to free cash.
| Year | Reinvestment Ratio | Operating CF (KRW) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2022 | 0.03x | ₩72.13 Billion | ₩2.06 Billion | — |